TSN084 Treating Patients With Advanced Malignant Tumors

Clinical trial NCT06386705 · UNKNOWN

Trial details

NCT number: NCT06386705
Sponsor: Tyligand Bioscience (Shanghai) Limited
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasm

Start date: 2022-07-20
Primary completion: 2025-12-30
Enrollment: 114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.